Webinar series on liquid biopsyCirculating cell-free DNA purification, sequencing and data interpretation Identification and monitoring of cancer mutations of circulating…
As the production of genome data and variant interpretation information skyrockets, scientists and clinicians are asking compelling new questions about…
We were honored to take part in last month’s Personalized Medicine World Conference (PMWC), where speakers and attendees focused on…
At the AGBT conference in Orlando we announced a new collaboration with 10x Genomics to co-market and co-develop NGS, single-cell…
The February 2016 issue of Medical Lab Observer features a story co-authored by two QIAGEN Bioinformatics executives, Ramon Felciano and…
The 2016 Personalized Medicine World Conference (PMWC) takes place on January 24-27 in Silicon Valley, California. Within the three days…
In this post, we share some of the trends and milestones that mattered most to us in 2015, and dust…
The EU funded PATHSEEK consortium, made up of four partners, is working towards a concept of sequencing whole pathogen genomes, e.g. HIV…
It’s exciting to see that NGS-related bioinformatics advances are having an impact in clinical labs. We’ve been following that trend…
It was great attending AMP. We not only announced enhancements to our QIAGEN Clinical Insight (QCI™) solution, but we also met…
It’s a pleasure to announce the introduction of our new GeneReader NGS System. Now, we’re offering a complete product suite across all…
We are pleased to announce the introduction of the GeneReader NGS System. We are now offering a complete product suite across all…
© QIAGEN 2017. All rights reserved - Trademarks & Disclaimers